192 related articles for article (PubMed ID: 23428841)
1. Lecithin/chitosan controlled release nanopreparations of tamoxifen citrate: loading, enzyme-trigger release and cell uptake.
Barbieri S; Sonvico F; Como C; Colombo G; Zani F; Buttini F; Bettini R; Rossi A; Colombo P
J Control Release; 2013 May; 167(3):276-83. PubMed ID: 23428841
[TBL] [Abstract][Full Text] [Related]
2. Ex vivo permeation of tamoxifen and its 4-OH metabolite through rat intestine from lecithin/chitosan nanoparticles.
Barbieri S; Buttini F; Rossi A; Bettini R; Colombo P; Ponchel G; Sonvico F; Colombo G
Int J Pharm; 2015 Aug; 491(1-2):99-104. PubMed ID: 26095916
[TBL] [Abstract][Full Text] [Related]
3. Melatonin-loaded lecithin/chitosan nanoparticles: physicochemical characterisation and permeability through Caco-2 cell monolayers.
Hafner A; Lovrić J; Voinovich D; Filipović-Grcić J
Int J Pharm; 2009 Nov; 381(2):205-13. PubMed ID: 19596430
[TBL] [Abstract][Full Text] [Related]
4. Comparative evaluation of in vitro parameters of tamoxifen citrate loaded poly(lactide-co-glycolide), poly(epsilon-caprolactone) and chitosan nanoparticles.
Cirpanli Y; Yerlikaya F; Ozturk K; Erdogar N; Launay M; Gegu C; Leturgez T; Bilensoy E; Calis S; Capan Y
Pharmazie; 2010 Dec; 65(12):867-70. PubMed ID: 21284254
[TBL] [Abstract][Full Text] [Related]
5. pH-responsive drug delivery of chitosan nanoparticles as Tamoxifen carriers for effective anti-tumor activity in breast cancer cells.
Vivek R; Nipun Babu V; Thangam R; Subramanian KS; Kannan S
Colloids Surf B Biointerfaces; 2013 Nov; 111():117-23. PubMed ID: 23787278
[TBL] [Abstract][Full Text] [Related]
6. Carboxymethyl chitosan/phospholipid bilayer-capped mesoporous carbon nanoparticles with pH-responsive and prolonged release properties for oral delivery of the antitumor drug, Docetaxel.
Zhang Y; Zhu W; Zhang H; Han J; Zhang L; Lin Q; Ai F
Int J Pharm; 2017 Oct; 532(1):384-392. PubMed ID: 28903067
[TBL] [Abstract][Full Text] [Related]
7. Artesunate-loaded chitosan/lecithin nanoparticles: preparation, characterization, and in vivo studies.
Chadha R; Gupta S; Pathak N
Drug Dev Ind Pharm; 2012 Dec; 38(12):1538-46. PubMed ID: 22348223
[TBL] [Abstract][Full Text] [Related]
8. Tamoxifen-loaded nanostructured lipid carrier as a drug delivery system: characterization, stability assessment and cytotoxicity.
How CW; Rasedee A; Manickam S; Rosli R
Colloids Surf B Biointerfaces; 2013 Dec; 112():393-9. PubMed ID: 24036474
[TBL] [Abstract][Full Text] [Related]
9. Dual drug delivery of tamoxifen and quercetin: Regulated metabolism for anticancer treatment with nanosponges.
Lockhart JN; Stevens DM; Beezer DB; Kravitz A; Harth E
J Control Release; 2015 Dec; 220(Pt B):751-7. PubMed ID: 26344396
[TBL] [Abstract][Full Text] [Related]
10. Tamoxifen citrate loaded amphiphilic beta-cyclodextrin nanoparticles: in vitro characterization and cytotoxicity.
Memisoglu-Bilensoy E; Vural I; Bochot A; Renoir JM; Duchene D; Hincal AA
J Control Release; 2005 Jun; 104(3):489-96. PubMed ID: 15911048
[TBL] [Abstract][Full Text] [Related]
11. Topotecan-tamoxifen duple PLGA polymeric nanoparticles: investigation of in vitro, in vivo and cellular uptake potential.
Khuroo T; Verma D; Talegaonkar S; Padhi S; Panda AK; Iqbal Z
Int J Pharm; 2014 Oct; 473(1-2):384-94. PubMed ID: 25051112
[TBL] [Abstract][Full Text] [Related]
12. Lecithin/chitosan nanoparticles for transdermal delivery of melatonin.
Hafner A; Lovrić J; Pepić I; Filipović-Grčić J
J Microencapsul; 2011; 28(8):807-15. PubMed ID: 22117177
[TBL] [Abstract][Full Text] [Related]
13. The role of the lecithin addition in the properties and cytotoxic activity of chitosan and chondroitin sulfate nanoparticles containing curcumin.
Jardim KV; Siqueira JLN; Báo SN; Sousa MH; Parize AL
Carbohydr Polym; 2020 Jan; 227():115351. PubMed ID: 31590861
[TBL] [Abstract][Full Text] [Related]
14. Lyophilized insulin nanoparticles prepared from quaternized N-aryl derivatives of chitosan as a new strategy for oral delivery of insulin: in vitro, ex vivo and in vivo characterizations.
Mahjub R; Radmehr M; Dorkoosh FA; Ostad SN; Rafiee-Tehrani M
Drug Dev Ind Pharm; 2014 Dec; 40(12):1645-59. PubMed ID: 24093431
[TBL] [Abstract][Full Text] [Related]
15. Tamoxifen citrate-loaded poly(d,l) lactic acid nanoparticles: Evaluation for their anticancer activity in vitro and in vivo.
Ravikumara NR; Bharadwaj M; Madhusudhan B
J Biomater Appl; 2016 Nov; 31(5):755-772. PubMed ID: 27664187
[TBL] [Abstract][Full Text] [Related]
16. Exploring the potential of lecithin/chitosan nanoparticles in enhancement of antihypertensive efficacy of hydrochlorothiazide.
Chadha R; Bhandari S; Kataria D; Gupta S; Singh Jain D
J Microencapsul; 2012; 29(8):805-12. PubMed ID: 22681125
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of cationic nanosystems with melatonin using an eye-related bioavailability prediction model.
Hafner A; Lovrić J; Romić MD; Juretić M; Pepić I; Cetina-Čižmek B; Filipović-Grčić J
Eur J Pharm Sci; 2015 Jul; 75():142-50. PubMed ID: 25869457
[TBL] [Abstract][Full Text] [Related]
18. The nasal delivery of nanoencapsulated statins - an approach for brain delivery.
Clementino A; Batger M; Garrastazu G; Pozzoli M; Del Favero E; Rondelli V; Gutfilen B; Barboza T; Sukkar MB; Souza SA; Cantù L; Sonvico F
Int J Nanomedicine; 2016; 11():6575-6590. PubMed ID: 27994459
[TBL] [Abstract][Full Text] [Related]
19. Ellagic acid encapsulated chitosan nanoparticles for drug delivery system in human oral cancer cell line (KB).
Arulmozhi V; Pandian K; Mirunalini S
Colloids Surf B Biointerfaces; 2013 Oct; 110():313-20. PubMed ID: 23732810
[TBL] [Abstract][Full Text] [Related]
20. Amphotericin-B entrapped lecithin/chitosan nanoparticles for prolonged ocular application.
Chhonker YS; Prasad YD; Chandasana H; Vishvkarma A; Mitra K; Shukla PK; Bhatta RS
Int J Biol Macromol; 2015 Jan; 72():1451-8. PubMed ID: 25453292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
